Jérôme de Sèze to Exanthema
This is a "connection" page, showing publications Jérôme de Sèze has written about Exanthema.
Connection Strength
0.094
-
Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD). Mult Scler Relat Disord. 2019 Apr; 29:7-14.
Score: 0.094